Faster access than browser!Similarities between Ankylosing spondylitis and TNF inhibitor
Ankylosing spondylitis and TNF inhibitor have 10 things in common (in Unionpedia): Adalimumab, Disease-modifying antirheumatic drug, Etanercept, Golimumab, Inflammation, Inflammatory bowel disease, Infliximab, Methotrexate, Psoriasis, Rheumatoid arthritis.
Adalimumab
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis.
Adalimumab and Ankylosing spondylitis · Adalimumab and TNF inhibitor ·
Disease-modifying antirheumatic drug
Disease-modifying antirheumatic drugs (DMARDs) is a category of otherwise unrelated drugs defined by their use in rheumatoid arthritis to slow down disease progression.
Ankylosing spondylitis and Disease-modifying antirheumatic drug · Disease-modifying antirheumatic drug and TNF inhibitor ·
Etanercept
Etanercept (trade name Enbrel) is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by acting as a TNF inhibitor.
Ankylosing spondylitis and Etanercept · Etanercept and TNF inhibitor ·
Golimumab
Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi.
Ankylosing spondylitis and Golimumab · Golimumab and TNF inhibitor ·
Inflammation
Inflammation (from inflammatio) is part of the complex biological response of body tissues to harmful stimuli, such as pathogens, damaged cells, or irritants, and is a protective response involving immune cells, blood vessels, and molecular mediators.
Ankylosing spondylitis and Inflammation · Inflammation and TNF inhibitor ·
Inflammatory bowel disease
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine.
Ankylosing spondylitis and Inflammatory bowel disease · Inflammatory bowel disease and TNF inhibitor ·
Infliximab
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.
Ankylosing spondylitis and Infliximab · Infliximab and TNF inhibitor ·
Methotrexate
Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.
Ankylosing spondylitis and Methotrexate · Methotrexate and TNF inhibitor ·
Psoriasis
Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin.
Ankylosing spondylitis and Psoriasis · Psoriasis and TNF inhibitor ·
Rheumatoid arthritis
Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints.
Ankylosing spondylitis and Rheumatoid arthritis · Rheumatoid arthritis and TNF inhibitor ·
The list above answers the following questions
- What Ankylosing spondylitis and TNF inhibitor have in common
- What are the similarities between Ankylosing spondylitis and TNF inhibitor
Ankylosing spondylitis and TNF inhibitor Comparison
Ankylosing spondylitis has 121 relations, while TNF inhibitor has 65. As they have in common 10, the Jaccard index is 5.38% = 10 / (121 + 65).
References
This article shows the relationship between Ankylosing spondylitis and TNF inhibitor. To access each article from which the information was extracted, please visit:
